These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 17259738

  • 1. Effects of dietary salt load and salt depletion on the course of hypertension and angiotensin II levels in male and female heterozygous Ren-2 transgenic rats.
    Husková Z, Kramer H, Vanourková Z, Thumová M, Malý J, Opocenský M, Skaroupková P, Kolský A, Vernerová Z, Cervenka L.
    Kidney Blood Press Res; 2007; 30(1):45-55. PubMed ID: 17259738
    [Abstract] [Full Text] [Related]

  • 2. Effects of changes in sodium balance on plasma and kidney angiotensin II levels in anesthetized and conscious Ren-2 transgenic rats.
    Husková Z, Kramer HJ, Vanourková Z, Cervenka L.
    J Hypertens; 2006 Mar; 24(3):517-27. PubMed ID: 16467655
    [Abstract] [Full Text] [Related]

  • 3. Inappropriately high circulating and intrarenal angiotensin II levels during dietary salt loading exacerbate hypertension in Cyp1a1-Ren-2 transgenic rats.
    Husková Z, Vanourková Z, Erbanová M, Thumová M, Opocenský M, Mullins JJ, Kramer HJ, Bürgelová M, Cervenka L.
    J Hypertens; 2010 Mar; 28(3):495-509. PubMed ID: 19927008
    [Abstract] [Full Text] [Related]

  • 4. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
    Mitchell KD, Bagatell SJ, Miller CS, Mouton CR, Seth DM, Mullins JJ.
    J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):74-86. PubMed ID: 17083061
    [Abstract] [Full Text] [Related]

  • 5. Effects of anesthesia on plasma and kidney ANG II levels in normotensive and ANG II-dependent hypertensive rats.
    Husková Z, Kramer HJ, Thumová M, Vanourková Z, Bürgelová M, Teplan V, Malý J, Cervenka L.
    Kidney Blood Press Res; 2006 Jun; 29(2):74-83. PubMed ID: 16651849
    [Abstract] [Full Text] [Related]

  • 6. Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition.
    Tokita Y, Franco-Saenz R, Mulrow PJ.
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):1031-9. PubMed ID: 8845072
    [Abstract] [Full Text] [Related]

  • 7. Acute effects of cyclooxygenase-2 inhibition on renal function in heterozygous ren-2-transgenic rats on normal or low sodium intake.
    Vanecková I, Cahová M, Kramer HJ, Husková Z, Skaroupková P, Komers R, Bader M, Ganten D, Cervenka L.
    Kidney Blood Press Res; 2004 Oct; 27(4):203-10. PubMed ID: 15273422
    [Abstract] [Full Text] [Related]

  • 8. Reduction of oxidative stress does not attenuate the development of angiotensin II-dependent hypertension in Ren-2 transgenic rats.
    Kopkan L, Husková Z, Vanourková Z, Thumová M, Skaroupková P, Malý J, Kramer HJ, Dvorák P, Cervenka L.
    Vascul Pharmacol; 2009 Oct; 51(2-3):175-81. PubMed ID: 19539780
    [Abstract] [Full Text] [Related]

  • 9. Salt-sensitive hypertension develops after transient induction of ANG II-dependent hypertension in Cyp1a1-Ren2 transgenic rats.
    Howard LL, Patterson ME, Mullins JJ, Mitchell KD.
    Am J Physiol Renal Physiol; 2005 Apr; 288(4):F810-5. PubMed ID: 15585671
    [Abstract] [Full Text] [Related]

  • 10. Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats.
    Chábová VC, Kramer HJ, Vanecková I, Vernerová Z, Eis V, Tesar V, Skaroupková P, Thumová M, Schejbalová S, Husková Z, Vanourková Z, Kolský A, Imig JD, Cervenka L.
    Vascul Pharmacol; 2007 Apr; 47(2-3):145-59. PubMed ID: 17604232
    [Abstract] [Full Text] [Related]

  • 11. Late-onset endothelin receptor blockade in hypertensive heterozygous REN-2 transgenic rats.
    Vernerová Z, Kramer HJ, Bäcker A, Cervenka L, Opocenský M, Husková Z, Vanourková Z, Eis V, Chábová VC, Tesar V, Malý J, Vanecková I.
    Vascul Pharmacol; 2008 Apr; 48(4-6):165-73. PubMed ID: 18372220
    [Abstract] [Full Text] [Related]

  • 12. Chronic endothelin receptor blockade reduces end-organ damage independently of blood pressure effects in salt-loaded heterozygous Ren-2 transgenic rats.
    Opocenský M, Dvorák P, Malý J, Kramer HJ, Bäcker A, Kopkan L, Vernerová Z, Tesar V, Zima T, Bader M, Ganten D, Janda J, Vanecková I.
    Physiol Res; 2004 Apr; 53(6):581-93. PubMed ID: 15588125
    [Abstract] [Full Text] [Related]

  • 13. Blockade of endothelin receptors attenuates end-organ damage in homozygous hypertensive ren-2 transgenic rats.
    Dvorák P, Kramer HJ, Bäcker A, Malý J, Kopkan L, Vanecková I, Vernerová Z, Opocenský M, Tesar V, Bader M, Ganten D, Janda J, Cervenka L.
    Kidney Blood Press Res; 2004 Apr; 27(4):248-58. PubMed ID: 15286437
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin II formation in the kidney and nephrosclerosis in Ren-2 hypertensive rats.
    Hartner A, Porst M, Klanke B, Cordasic N, Veelken R, Hilgers KF.
    Nephrol Dial Transplant; 2006 Jul; 21(7):1778-85. PubMed ID: 16522658
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats.
    Rakusan D, Kujal P, Kramer HJ, Husková Z, Vanourková Z, Vernerová Z, Mrázová I, Thumová M, Cervenka L, Vanecková I.
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F758-66. PubMed ID: 20668096
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.